Details for Patent: 8,883,842
✉ Email this page to a colleague
Which drugs does patent 8,883,842 protect, and when does it expire?
Patent 8,883,842 protects FARYDAK and is included in one NDA.
This patent has twenty-four patent family members in eighteen countries.
Summary for Patent: 8,883,842
| Title: | Use of HDAC inhibitors for the treatment of myeloma |
| Abstract: | The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of formula (I) ##STR00001## wherein the radicals and symbols have the meanings as defined in the specification, for the preparation of a medicament for the treatment of myeloma, in particular, multiple myeloma, especially myeloma which is resistant to conventional chemotherapy; to a combination comprising an HDAC inhibitor and a compound effecting apoptosis of myeloma cells, preferably bortezomib, for simultaneous, separate or sequential use; to methods of treating myeloma; and to a pharmaceutical composition comprising said combination. |
| Inventor(s): | Atadja; Peter W (Acton, MA) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 12/717,373 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,883,842
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-001 | Feb 23, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE | ⤷ Sign Up | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE | ⤷ Sign Up | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,883,842
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1912640 | ⤷ Sign Up | PA2016003 | Lithuania | ⤷ Sign Up |
| European Patent Office | 1912640 | ⤷ Sign Up | C20160001 00181 | Estonia | ⤷ Sign Up |
| European Patent Office | 1912640 | ⤷ Sign Up | PA2016003,C1912640 | Lithuania | ⤷ Sign Up |
| Australia | 2006278718 | ⤷ Sign Up | |||
| Brazil | PI0614090 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
